Vascular Access

Vascular therapies represent an alternative to traditional invasive surgical techniques for the treatment of disease such as coronary artery disease. Vascular therapies improve patient comfort by reducing pain and risk as well as yielding quicker recovery at lower cost.

Engineered polymer resins from Lubrizol are well suited for use in endovascular medical devices (used in the treatment of cardiovascular, peripheral vascular and neurovascular diseases) because of their biocompatibility, biostability and in-dwelling softening characteristics.

Potential applications include:

• Central Venous Catheters (CVC)
• Peripherally Inserted Central Catheter (PICC)
• Dialysis Catheters

The information contained herein is believed to be reliable, but no representations, guarantees or warranties of any kind are made as to its accuracy, suitability for particular applications or the results to be obtained. The information is based on laboratory work with small-scale equipment and does not necessarily indicate end product performance. Because of the variations in methods, conditions and equipment used commercially in processing these materials, no warranties or guarantees are made as to the suitability of the products for the applications disclosed. Full-scale testing and end product performance are the responsibility of the user. Lubrizol Advanced Materials, Inc. shall not be liable for and the customer assumes all risk and liability of any use or handling of any material beyond Lubrizol Advanced Materials, Inc.'s direct control. The SELLER MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. Nothing contained herein is to be considered as permission, recommendation, nor as an inducement to practice any patented invention without permission of the patent owner.